Hypoxic preconditioning triggers myocardial angiogenesis: a novel approach to enhance contractile functional reserve in rat with myocardial infarction.
A modern experimental strategy for treating myocardial ischemia is to induce neovascularization of the heart by the use of "angiogens", mediators that induce the formation of blood vessels, or angiogenesis. Studies demonstrated that coronary collateral vessels protect ischemic myocardium after coronary obstruction; therefore we sought to examine a novel method of stimulating myocardial angiogenesis through hypoxic preconditioning at both capillary (using anti-CD31) and arteriolar (using anti- alpha smooth muscle actin) levels and also investigate whether such treatments could preserve left ventricular contractile functional reserve and regional blood flow by increasing vascular endothelial growth factor (VEGF). Male Sprague-Dawley rats were randomly divided into four groups: normoxia+sham surgery (CS), normoxia+permanent left anterior descending coronary artery (LAD) occlusion (CMI), hypoxic preconditioning+sham surgery (HS) and hypoxic preconditioning+permanent LAD occlusion (HMI). Rats in the preconditioned groups were subjected to systemic hypoxemic hypoxic exposure (10+/-0.4% O(2)) for 4 h followed by a 24 h period of normoxic reoxygenation prior to undergoing LAD occlusion. Rats in the normoxia group were time matched with the preconditioned group and maintained under normoxic conditions for a 28 h period prior to LAD occlusion. Western blot analysis was performed to measure VEGF expression and TUNEL staining with endothelial cell-specific antibody, anti-VWF, was used to examine endothelial apoptosis. One, two and three weeks after the LAD occlusion, baseline left ventricular pressures were monitored and recorded. Pharmacological stress tests with dobutamine infusion in progressively increasing doses revealed significantly elevated contractile reserve at each dose point in the HMI group compared to the CMI group. The HMI group displayed statistically significant increases in capillary as well as arteriolar density after 1, 2 and 3 weeks post-operation. Blood flow was also significantly elevated in the HMI groups when compared to the CMI group. The extent of endothelial cell apoptosis was found to be inversely proportional to VEGF expression. It was concluded that hypoxic preconditioning stimulates myocardial angiogenesis to an extent sufficient to exert significant cardioprotection in a rat model of myocardial infarction progressing to heart failure as evidenced by increased capillary/arteriolar density and enhanced ventricular contractile functional reserve.
Sasaki
Hiroaki
H
Department of Surgery, University of Connecticut Health Center, Farmington, Connecticut 06030-1110, USA.
Fukuda
Shoji
S
Otani
Hajime
H
Zhu
Li
L
Yamaura
Genbu
G
Engelman
Richard M
RM
Das
Dipak K
DK
Maulik
Nilanjana
N
D000818:Animals; D017209:Apoptosis; D001160:Arterioles / Q000187:drug effects / Q000254:growth & development / Q000502:physiology; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D015153:Blotting, Western; D002196:Capillaries / Q000187:drug effects / Q000254:growth & development / Q000502:physiology; D003326:Coronary Circulation; D003331:Coronary Vessels / Q000187:drug effects / Q000254:growth & development* / Q000502:physiology; D004280:Dobutamine / Q000494:pharmacology; D016228:Endothelial Growth Factors / Q000378:metabolism; D004730:Endothelium, Vascular / Q000473:pathology; D006339:Heart Rate / Q000187:drug effects; D000860:Hypoxia / Q000097:blood*; D020287:In Situ Nick-End Labeling; D019157:Ischemic Preconditioning, Myocardial; D008222:Lymphokines / Q000378:metabolism; D008297:Male; D009203:Myocardial Infarction / Q000097:blood* / Q000473:pathology / Q000517:prevention & control*; D018919:Neovascularization, Physiologic; D010100:Oxygen / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D016277:Ventricular Function, Left / Q000187:drug effects / Q000502:physiology*
D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D004280:Dobutamine; D010100:Oxygen